Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Zerbib

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Frontiers in Surgery|October 5, 2018
Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World ExperienceThanh-Tuan Nguyen, Olivier Huillard, Yohann Dabi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2002
[Study of intermittent endocrine therapy in patients presenting with biologic recurrence after radical prostatectomy or radiotherapy]Alexandre de la Taille, Marc Zerbib, Sophie Conquy, et al.
The Journal of Urology|July 14, 2015
Gleason Score Determination with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Guided Prostate Biopsies--Are We Gaining in Accuracy?Camille Lanz, François Cornud, Frédéric Beuvon, et al.
World Journal of Urology|October 17, 2017
Impact of body mass index on the oncological outcomes of patients treated with radical nephroureterectomy for upper tract urothelial carcinomaYohann Dabi, Mohammed El Mrini, Igor Duquesnes, et al.
Clinical Chemistry|October 10, 2012
TMPRSS2-ERG fusion transcripts in matched urine and needle rinse material after biopsy for the detection of prostate cancerPhuong-Nhi Bories, Patrick Younes, Marc Zerbib, et al.
European Urology|November 14, 2006
Identification of risk factors for voiding dysfunction following TVT placementAmbroise Salin, Sophie Conquy, Caroline Elie, et al.
Urology|February 6, 2007
Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassificationGéraldine Pignot, Caroline Elie, Sophie Conquy, et al.
European Urology|July 6, 2007
Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA eraAurelien Descazeaud, Michael Peyromaure, Ambroise Salin, et al.
Presse Medicale (Paris, France : 1983)|August 5, 2018
The visual prostate symptom score is a simple tool to identify and follow up in general practice patients with lower urinary tract symptoms associated with benign prostatic hyperplasia (a study with 1359 patients)Aurélien Descazeaud, Patrick Coloby, Alexandre De La Taille, et al.
Plos Pathogens|July 9, 2011
HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cellsZhicheng Zhou, Nicolas Barry de Longchamps, Alain Schmitt, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Frontiers in Surgery|October 5, 2018
Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World ExperienceThanh-Tuan Nguyen, Olivier Huillard, Yohann Dabi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2002
[Study of intermittent endocrine therapy in patients presenting with biologic recurrence after radical prostatectomy or radiotherapy]Alexandre de la Taille, Marc Zerbib, Sophie Conquy, et al.
The Journal of Urology|July 14, 2015
Gleason Score Determination with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Guided Prostate Biopsies--Are We Gaining in Accuracy?Camille Lanz, François Cornud, Frédéric Beuvon, et al.
World Journal of Urology|October 17, 2017
Impact of body mass index on the oncological outcomes of patients treated with radical nephroureterectomy for upper tract urothelial carcinomaYohann Dabi, Mohammed El Mrini, Igor Duquesnes, et al.
Clinical Chemistry|October 10, 2012
TMPRSS2-ERG fusion transcripts in matched urine and needle rinse material after biopsy for the detection of prostate cancerPhuong-Nhi Bories, Patrick Younes, Marc Zerbib, et al.
European Urology|November 14, 2006
Identification of risk factors for voiding dysfunction following TVT placementAmbroise Salin, Sophie Conquy, Caroline Elie, et al.
Urology|February 6, 2007
Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassificationGéraldine Pignot, Caroline Elie, Sophie Conquy, et al.
European Urology|July 6, 2007
Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA eraAurelien Descazeaud, Michael Peyromaure, Ambroise Salin, et al.
Presse Medicale (Paris, France : 1983)|August 5, 2018
The visual prostate symptom score is a simple tool to identify and follow up in general practice patients with lower urinary tract symptoms associated with benign prostatic hyperplasia (a study with 1359 patients)Aurélien Descazeaud, Patrick Coloby, Alexandre De La Taille, et al.
Plos Pathogens|July 9, 2011
HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cellsZhicheng Zhou, Nicolas Barry de Longchamps, Alain Schmitt, et al.
Pageof 15